We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Mater is committed to engaging with our consumers to support the successful integration of health, education and research for a healthy community.
Mater Group is proud to mark a milestone in its history, the launch of a new brand, to reposition Mater as a group incorporating health, education and research for a ...
The Mater Rockhampton Cardiac Catheterisation and Angiography Laboratory has treated the 100th patient since opening a few short months ago.
A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.
The team at Clarence Street, Mater Young Adult Health Centre Brisbane, are celebrating National Recycling Week (12 to 18 November) with their pet composting worms!
Mater is proud to officially welcome Professor Patrick Chauvel as Professorial Research Fellow at Mater Research.
Meet Chris McGwinn, a Registered Training Organisation instructor at Mater Education for the vocational education and training in schools program.
A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.
Mater Education’s Director of Clinical Training, Dr Ryan Frazer, has been awarded Queensland Clinical Educator of the Year by the Confederation of Postgraduate ...
Mater Pastoral Care Practitioner Rebekah Durham was on track for a career in journalism when a university assignment highlighted how her personality and skillset were ...
A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).
Mater recently celebrated its cultural heritage with the Mercy Day Mission Awards ceremony, presenting two awards to Mater People who embody the Mater Values.